What Is It?
Sanofi is committed to collaborating with partners to advance cutting-edge discoveries into transformative medicines that improve patient lives. The Sanofi Innovation Awards (iAwards) program, created in 2015, was designed to do just that.
In 2025, iAward launched in China for the first time.
About the Program
-
Seed funding of ￥1 000 000 CNY
-
12-month duration
-
Dedicated Sanofi Project Champion and resources (subject matter experts)
-
A steppingstone to further collaboration
Who Are We Looking For?
Who are we seeking? Principal investigators at our partner academic and clinical institutions who are advancing breakthrough concepts and therapies in key areas.
- Immunology & Inflammation
- Rare Diseases
- Neurology
- Ophthalmology
- Oncology
- Target, Disease and Systems Biology（TDSB）
- Vaccines
Sanofi iAwards China 2026 has completed the initial call for submissions and is currently under review. Next Call for Projects: Spring 2027
Our Selection Process
A fast process to select and start projects in less than 8 months
Week 0
+8 Weeks
+4 Weeks
+6 Weeks
+4 Weeks
Final selection by Sanofi experts
+8 Weeks
iAward Recipients for the 2025-2026 Cycle
Tao YANG
The First Affiliated Hospital with Nanjing Medical University
Jie LIN
Huashan Hospital, Fudan University
Ligang WU
Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences
For more information about iAwards
Contact EI-CN@sanofi.com